Literature DB >> 1880886

Ocular cicatricial pemphigoid occurring as a sequela of Stevens-Johnson syndrome.

L S Chan1, H K Soong, C S Foster, C Hammerberg, K D Cooper.   

Abstract

Ocular cicatricial pemphigoid is a chronic scarring inflammation of the ocular mucosae that can lead to blindness. Although cicatricial pemphigoid has been classified clinically, histopathologically, and immunopathologically, no definite initiating factor or precipitating factor has been identified. In this report, we describe five cases of ocular cicatricial pemphigoid that developed following an acute episode of severe ocular inflammatory injury secondary to Stevens-Johnson syndrome. The time lag between the onset of Stevens-Johnson syndrome and cicatricial pemphigoid ranged from a few months to 31 years. All five patients had linear immune deposits characteristic of cicatricial pemphigoid along the basement membrane zone of mucosal biopsy specimens as detected by either direct immunofluorescence microscopy or direct immunoperoxidase staining. In two patients whose serum was tested, a Western blot assay taken of keratinocyte antigens that had undergone electrophoresis reacted with the serum and identified a 120-kd epidermal antigen detected by the IgG class antibodies. All five patients were treated with systemic immunosuppressive therapy for cicatricial pemphigoid, and we obtained objective responses. Severe ocular mucosal injury such as that which occurs in Stevens-Johnson syndrome may be a precipitating factor in the development of ocular cicatricial pemphigoid.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1880886

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  7 in total

1.  Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously.

Authors:  L R Zakka; D B Keskin; P Reche; A R Ahmed
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

2.  Ectopic conjunctivalisation in Stevens-Johnson syndrome.

Authors:  S E Navon; P A Rubin
Journal:  Br J Ophthalmol       Date:  1994-09       Impact factor: 4.638

Review 3.  The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on.

Authors:  J K Dart
Journal:  Eye (Lond)       Date:  2017-01-20       Impact factor: 3.775

4.  The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy.

Authors:  M Victoria De Rojas; John K G Dart; Valerie P J Saw
Journal:  Br J Ophthalmol       Date:  2007-02-21       Impact factor: 4.638

5.  Elevation of conjunctival epithelial CD45INTCD11b⁺CD16⁺CD14⁻ neutrophils in ocular Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Geraint P Williams; Paul J Tomlins; Alastair K Denniston; H Susan Southworth; Sreekanth Sreekantham; S John Curnow; Saaeha Rauz
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-10       Impact factor: 4.799

6.  Desquamative gingivitis - A clinical sign in mucous membrane pemphigoid: Report of a case and review of literature.

Authors:  Shamimul Hasan
Journal:  J Pharm Bioallied Sci       Date:  2014-04

Review 7.  Humoral Epitope Spreading in Autoimmune Bullous Diseases.

Authors:  Dario Didona; Giovanni Di Zenzo
Journal:  Front Immunol       Date:  2018-04-17       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.